Sohail Ikram
Overview
Explore the profile of Sohail Ikram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Singam N, Burkhart T, Ikram S
Methodist Debakey Cardiovasc J
. 2019 Nov;
15(3):223-225.
PMID: 31687103
Anomalous origin of the right coronary artery (ARCA) is an extremely rare cardiac pathology. The coronary artery can potentially course between the aorta and the pulmonary artery, putting the patient...
12.
Bhatia N, Sawyer R, Ikram S
Methodist Debakey Cardiovasc J
. 2018 May;
13(4):248-252.
PMID: 29744018
Eptifibatide is a glycoprotein (GP) IIb/IIIa inhibitor used mostly in the treatment of acute coronary syndrome (ACS). The GP IIb/IIIa antagonists occupy the fibrinogen binding site at the GP IIb/IIIa...
13.
Ikram S, Pachika A, Schuster H, Ghotra A, Dotson L, Akbar S, et al.
South Med J
. 2018 May;
111(4):226-229.
PMID: 29719035
Objectives: The objective of this study was to identify risk factors and clinical profile of the patients presenting with ST elevation myocardial infarction (STEMI). We further evaluated the utility of...
14.
Tripathi A, Abbott J, Fonarow G, Khan A, Barry 4th N, Ikram S, et al.
Circ Cardiovasc Interv
. 2017 Dec;
10(12).
PMID: 29246918
Background: The association of short-term readmissions after percutaneous coronary intervention (PCI) on healthcare costs has not been well studied. Methods And Results: The Healthcare Cost and Utilization Project National Readmission...
15.
Khan A, Bavishi C, Riaz H, Farid T, Khan S, Atlas M, et al.
Circ Cardiovasc Qual Outcomes
. 2017 Jan;
10(1).
PMID: 28073851
Background: There is encouraging evidence of the efficacy of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors; however, their long-term safety remains unclear. We performed a meta-analysis of studies to evaluate...
16.
Ikram S, Saleem N, Latif R
J Anesth
. 2016 Jul;
30(5):911-4.
PMID: 27468734
Reverse takotsubo cardiomyopathy (TCM) is a less common variant of classic TCM that presents within a different patient profile and with its own hemodynamic considerations. A 46-year-old woman was admitted...
17.
Ikram S, Kandasamy V
Cardiovasc Interv Ther
. 2016 May;
32(3):244-246.
PMID: 27146134
A 73-year-old male underwent cardiac catheterization and received two Everolimus drug eluting stents for 80 % stenotic lesions in the left anterior descending and right coronary arteries. He was discharged...
18.
19.
20.
Khalid N, Iqbal I, Coram R, Raza T, Fahsah I, Ikram S
Int J Cardiol
. 2015 May;
191:107-8.
PMID: 25965614
No abstract available.